Abstract: The present investigation was directed towards the synthesis of a copolymer of vinyl acetate, butyl acrylate, 2-ethylhexyl acrylate, methacrylic acid and acrylamide to be exploited as a pressure sensitive adhesive (PSA) in transdermal drug delivery systems. The experimental methodology involved the optimization of reaction conditions for the polymer synthesis. The optimal synthesis conditions of PSA were determined as that polymerization reaction of PSA in ethyl acetate with BPO of 0.5% w/w of reactants at 75 o C throughout the whole process with polymerization reaction time of eight hours. The copolymer was then characterized by FTIR, 1 H-NMR, 13 C-NMR and DSC. The PSA was also evaluated for residual monomer content, viscosity, tack, peel adhesion and drug release behavior. The synthesized PSA's tack is 21#; peel adhesion is 1.39 N/mm. And the residual monomers content in the copolymer after polymerizing for eight hours are VAc 2.98%, BA 0.004%. The PSA also exhibited excellent drug release behavior. Membranes containing oxybutynin were capable of releasing in zero order fashion. It was found that the release velocity depended on the concentration of modified monomer. Drug release from those membranes could be easily tailored by changing the content of the modified monomers. It was found suitable for use in transdermals and could be further exploited either as an adhesive or as a system component in the area of transdermal drug delivery.
Introduction
Transdermal drug delivery (TDD) systems are drug-loaded adhesive patches which, when applied to the skin, deliver the therapeutic agent, at a controlled rate, through the skin to the systemic circulation and to the target organs. TDD systems, as compared to their corresponding classical oral or injectable dosage from counterparts, offer many advantages [1] [2] [3] . The most important advantages are improved systemic and pharmaceutical bioavailability of the pharmaceutical active ingredients (PAI), because the first-pass metabolism by the liver and digestive system is avoided and the controlled, constant drug delivery profile (that is, controlled zero-order absorption). Another importance is the reduced dose frequency compared with the conventional oral dosage forms (that is, once-a-day, twice-a-week or once-aweek). Other benefits include longer duration of the therapeutic action from a single application, and reversible action. For example, patches can be removed to reverse any adverse effects that may be caused by overdosing.
Adhesives are critical component in transdermal drug delivery (TDD) devices, which are used to maintain intimate contact between the patch and the skin surface. Pressure sensitive adhesives (PSAs) are generally defined as materials that adhere to a substrate with light pressure and which leave no residual adhesive upon their removal [4] . They offer the advantages of convenience of use (PSAs do not require water/solvents or heat in order to achieve adhesion), good stability (PSAs are generally not sensitive to environmental humidity or temperature degradation) simplicity of manufacture, and good appearance [5] . In addition to the usual requirements of functional adhesive properties, such as adequate tack, skin-adhesion and cohesive strength, there are other factors to be considered in the selection and use of PSAs for TDD systems. These include biocompatibility, formulation, compatibility, delivery system compatibility, and acceptable regulatory status (that is, the availability of drug master files or equivalent supporting documentation). Biocompatibility requires that the PSAs are biologically inert, non-irritating and nonsensitizing to skin, and have non systemic toxicity. Formulation compatibility requires that the PSAs do not induce drug or excipient degradation, do not react with the drug and other formulation components, maintain stability and functional properties when formulated, and offer the desired solubility. Delivery system compatibility requires that the PSAs provide adequate diffusivity and permeability to the drug and/or permeation enhancers [6, 7] .
Poly-acrylate, or more precisely poly(acrylic esters), have been known for a long time. They have been referred to as acrylic polymers, or simply acrylics or acrylate. Acrylic PSAs offer advantages of good compatibility with a wide range of drugs and excipients, ease of processing, and flexibility in tailoring the polymer properties. Acrylics are saturated hydrocarbon polymers. They are therefore highly resistant to oxidation, and do not require the addition of stabilizes, which have the potential to cause skin irritation. The acrylic polymers have a low T g (-55 to -15 o C) and are inherently tacky, and therefore in general they do not require low molecular weight tackifiers and plasticizers to provide the tack and softness. The organic solventbased acrylic PSA prepared directly from polymerization are the final, ready-to-use adhesives.
In this paper, three monomers that have been extensively used as major adhesive component include: vinyl acetate, butyl acrylate and 2-ethylhexyl acrylate. Incorporation of ester groups with longer chain lengths increases the randomness of the acrylate polymer, which reduces the crystallinity and lowers the glass transition temperature [8] . A large variety of monomers are also employed as modifiers for the long chain acrylate. In addition, two kinds of monomers with functional groups are also used in the polymerization of acrylic PSA. Addition of a small amount of acrylamide and other functional monomers promotes the adhesion and increases the moisture permeability of the polymer. And then the adhesive characters, solid content, 1 H and 13 C NMR spectrum, the glass transition residual monomers and drug release behavior were also investigated. The synthesized solvent-based acrylic adhesive was applied to the transdermal drug delivery systems. The adhesive maintains a tack and peel adhesion with the surface. In addition to the usual requirements of pressure sensitive properties, the adhesive is also nonirritating to skin and compatible with drugs. It can be release drugs in zero order fashion.
Results and discussion

Optimization of reaction conditions
Solvent plays an important role in free radical solution polymerization. It has an influence on the chain transfer reactions during polymerization process. In addition, the decomposition rate of BPO is known to vary in different solvents [9] . It was observed in Table 1 that the solid content, viscosity, tack and peel adhesion of the synthesized copolymer were found to be high in ethyl acetate solvents compared with cyclohexane and methylbenzene. This could be attributed to the high polar nature of this solvent. Hence, ethyl acetate was selected as the solvent for further studies. Increasing the reaction time could result in cross-linking (by chain propagation) thereby affecting the molecular weight of the polymer reflected by a corresponding increase in the viscosity and solid content. Table 2 shows the effect of reaction time on solid content and adhesive character.
From Fig. 1 it is seen that an increase in the initiator concentration led to a decrease in the degree of polymerization thus resulting in polymers of low molecular weight. When initiator concentration rose from 0.2% to 0.5% w/w, there is a notable increase in solid content, but when initiator concentration rose from 0.5% to 0.8% w/w, increase of the solid content is not obvious. At the initiator concentration of 0.5% w/w there was a higher value of viscosity and adhesive characters of the copolymer, respectively, but after that point there was a decrease in viscosity and adhesive characters of the copolymer. An initiator concentration of 0.5% w/w was considered as optimum for the polymerization process.
High temperature would result in a faster decomposition of the initiator, thereby increasing the reaction rate. At very low temperatures, the initiator may fail to decompose. From the experimental results of varying temperature (Table 3) , it was found that a reaction temperature of 75 o C, nearly circumfluence temperature was optimum to obtain the copolymer with high solid content and good adhesive characters. Thus, the optimum conditions for synthesis of copolymer included a reaction time of 8 hours, using ethyl acetate as solvent, an initiator concentration of 0.5% w/w at a controlled temperature of 75 o C.
Tab. 3.
Influence of temperature on solid content, viscosity, tack, peel adhesion. Characterization of copolymer
The IR spectrum of polymer ( Fig. 2) shows a peak at 3445.9 cm -1 due to N-H stretching vibration of the amide. 1 H-NMR of copolymer -13 C-NMR spectra The 13 C-NMR for the polymer sample was recorded and is shown in Fig. 4 and Fig. 5 is the index of 13 C-NMR. In Fig.4 the resonance signal at 174.51 ppm is due to the carbonyl carbon (C 1 ). The resonance signal at 70.00 ppm is due to the ethane ester carbon (C 2 ). The peak due to the methane carbon of 2-ethylhexyl acrylate (C 3 ) is observed at 66.95 ppm. The resonance signal at 64.39 ppm is due to the methane carbon of butyl acrylate (C 4 ). The resonance signal due to the carbonyl carbon of butyl acrylate and 2-ethylhexyl acrylate (C 5 ) is observed at 41.44 ppm. The resonance signal at 38.54 ppm is due to the β-C carbon of 2-ethylhexyl acrylate and butyl acrylate (C 6 ). The butyl acrylate carbon (C 7 ) shows signal at 30.57 ppm. The other 2-ethylhexyl acrylate carbon signals are observed at 30.18 ppm (C 8 ), 28.85 ppm (C 9 ), 23.55 ppm (C 10 ), 22.93 ppm (C 11 ), 1.03 ppm (C 14 ) and 10.76 ppm (C 16 ). The resonance signal at 20.81 ppm is due to vinyl acetate carbon (C 12 ). The peak at 19.07 ppm is due to butyl acrylate and 2-ethylhexyl acrylate (C 13 ). The resonance signal at 13.69 ppm is due to butyl acrylate carbon (C 15 ).
Fig. 4.
13 C-NMR of copolymer. -Solubility For solubility studies, about 100 mg of the polymer was transferred into closed test tubes containing 5 mL of the solvent. The tubes were kept at room temperature for 24 hours with occasional agitation. The solvents tried were acetone, chloroform, tetrahydrofuran, toluene, petroleum ether, methanol, isopropyl alcohol, etc. The tubes were inspected visually after 24 hours for swelling and signs of solubilization. The copolymer was considered soluble in those solvents when copolymer solution appeared clear and homogeneous in vision. It was considered insoluble in solvents where the copolymer was poorly wetted or unchanged. The results show that copolymer is soluble in cyclohexane, acetone, chloroform, tetrahydrofuran, toluene and petroleum ether and insoluble in ethanol, methanol and isopropyl alcohol. 
Determination of residual monomers
A main problem with this acrylic PSAs is the residual monomers, which can migrate from the product and be in contact with user's skin, resulting in irritation to skin and mucous membranes. Moreover, the medicine must be blended with PSAs before paste to human skin [11] . The absorption and function of the medicine can be impacted by residual monomers in acrylic PSAs. Therefore, the residual monomers content is a critical factor for PSAs evaluation. The effect of polymerization time on residual monomers content in PSAs was investigated.
Contents of residual monomers in the PSAs obtained from different polymerization time were analyzed and calculated using the proposed method. The results are listed in Table 4 .
Tab. 4. Residual monomers of resin at different polymerization time. Polymerization time (h)
VAc ( The levels of residual monomers concentration in these samples are decreased with increase of polymerization time. This indicates that the PSAs product with lower residual monomers product can be obtained by prolonging polymerization time. The residual monomers of PSAs after eight hours polymerization could be qualified to the medical usage.
Drug release behavior [12]
The drug release profile depends on the content of the modifiers when the kind of major monomer and T g of copolymer are given. Thus, it is important to understand the impact of different content of modified monomer, methacrylic acid. The loading of oxybutynin into membrane was carried out at 25 o C, and it was released by soaking the membrane into water at different content of methacrylic acid. All the devices delivered the oxybutynin within 24 h. The release profiles are shown in Fig. 7 . It is observed that when concentration of methacrylic acid increased, release velocity of oxybutynin slowed down. Drug release from these membranes could be easily tailored by changing the content of the modified monomers. Membranes were capable of releasing oxybutynin in zero order fashion. 
Conclusions
The objective of this paper was to synthesize a kind of acrylic PSA suited to the transdermal drug delivery systems. The solution polymerization method was applied in the process of PSA preparation. The optimal synthesis conditions of PSA are determined as that polymerization reaction of PSA in ethyl acetate with BPO with 0.5% w/w of reactants at 75 o C throughout the whole process and polymerization reaction time of eight hours. The structure of as-synthesized PSA was characterized by FTIR, 1 H NMR and 13 C NMR spectra. The glass transition temperature, residual monomers and drug release behavior were also investigated. The synthesized PSA's tack is 21#; peel adhesion is 1.39 N/mm. And the residual monomers content in the copolymer after polymerizing for eight hours are VAc 2.98%, BA 0.004%. It also exhibited excellent drug release behavior. Membranes containing oxybutynin were capable of releasing in zero order fashion. All these properties make as-synthesized PSA suitable for use in transdermal drug delivery. It could also be employed as a system component in the area of other transdermals. 
Experimental part
Materials
Ethyl acetate (AR) was purchased from Beihua Co. ltd., Beijing. Butyl acrylate (AR), 2-ethylhexyl acrylate (AR) and benzoyl peroxide (BPO, AR) were purchased from Beijing reagent Co. ltd., Beijing. Vinyl acetate (CP) was provided by Yili Shiji Co. ltd., Beijing. Methacrylic acid was obtained from Fuchen shiji Co. ltd., Tianjin. Acrylamide was provided by Letai Co. ltd., Tianjin. Some chemical structures are presented in Fig. 8 . 2-EHA was freed from its inhibitor by washing with 5% sodium hydroxide solution saturated with sodium chloride. It was subsequently washed with water to remove traces of alkali and dried over anhydrous sodium sulphate. Butyl acrylate and vinyl acetate were purified by vacuum distillation. The purified monomers were refrigerated till use.
General method of chemical polymerization
Acrylate copolymer was obtained from a solution polymerization process. It was synthesized in term of Fig. 9 .
The PSAs samples were synthesized with 11wt% vinyl acetate, 16 wt% butyl acrylate and 18 wt% 2-ethylhexyl acrylate in 55 wt% ethyl acetate initiated by 0.1 wt% BPO. As a typical case, in the following, the preparation method for acrylic copolymers is described. Vinyl acetate (17.5 g, 203.3 mmol), butyl acrylate (26.5 g, 206.8 mmol), BPO (0.03 g, 0.10 mmol) and ethyl acetate (75 g) were added into a four-necked flask, which was equipped with a mechanical stirrer, a nitrogen gas inlet, a thermometer (100 o C) and a condenser. Purging by nitrogen gas till 70 o C, 2-ethylhexyl acrylate (31.3 g, 169.7 mmol) with BPO (0.13g, 0.52 mmol) was added drop-wise into the solution. After dropping reactant, polymerization reaction was continued for 8 h at 75 o C. The obtained polymer was clear viscous liquid.
Fig. 9. Synthesis reaction equation of acrylic PSAs.
Optimization of reaction conditions for polymer synthesis
The effect of various reaction parameters like type of solvent, time of reaction, initiator concentration and reaction temperature on the adhesive property of the polymer was studied. Adhesive characters were taken as the criteria for selection. The conditions that gave a polymer with the outstanding adhesive characters were considered to be optimum.
Solvent may change the monomer reactivity ratio and monomer association during the polymerization process and thus influence viscosity and adhesive characters of the polymer [13] . Different solvents like ethyl acetate, methylbenzene and cyclohexane were used to study the effect of solvent on the adhesive characters of the polymer. In addition, the effect of varying reaction time viz. 4, 6 and 8 hours on solid content and residual monomers in acrylic PSAs were assessed. The degree of polymerization is inversely proportional to the initiator concentration [14] . Initiator concentrations of 0.1%, 0.2%, 0.3%, 0.4% and 0.5% w/w were tried and its effect on solid content was determined. Temperature was also found to influence both the degree and the rate of polymerization. The polymerization rate was found to increase rapidly with increase of reaction temperature while the degree of the polymerization decreases. The polymerization reactions were carried out at three different temperatures viz. 70 o C, 75 o C and 80 o C to evaluate the effect of temperature on solid content.
Polymer characterization
Gravimetric analysis was performed to determine solid content of the final product. Approximately 0.5 g solution was transferred to a pre-weighed vial and weighed. The polymer was dried out of the solvent to constant weight. The polymer was subsequently washed with methanol two times to remove unreacted monomers and initiator. Residual methanol was evaporated off using a vacuum oven. The solid content of the solution was calculated as follows. 
The 1 H and 13 C NMR spectrum were recorded using a Bruker AV-600 spectrometer. Polymer solution was made in spectroscopic grade deuterated chloroform and the spectrum was recorded at ambient temperature.
The glass transition temperature, T g , was determined by differential scanning calorimetry (DSC) on a NETZSCH DSC 204 F1 thermal analyzer. The sample was sealed in an aluminium cell and was cooled to liquid nitrogen temperature. The heating rate was programmed at 10 o C/min and alumina was used as the reference standard. The temperature range was set at -80 to 0 o C.
The concentration of residual monomers in synthesized polymers was determined by gas chromatography (GC). The polymer was extracted in acetone, suitably diluted and subjected to GC analysis. The polymer specimens of approximately 2 g were introduced into 10 mL volumetric glass flasks, then 10 mL of acetone as extractant was poured into the flask, the specimens were extracted for 60 minutes through ultrasonic extraction (CW-2000, Shanghai Xintuo Analytical Instruments Co., Ltd). The chromatogram was observed for any monomer peaks. All measurements were carried out using Model 6890N Network Gas system (Agilent, USA) with flame ionization detector and 7683 Series injector (Agilent, China), equipped with a DB-1 capillary column (30 m long×320 μm i.d. with 1 μm film thickness). GC conditions were: Temperatures for injector and detector were 250 o C and 280 o C, respectively, and the column temperature was programmed from 45 o C (hold 2 min) to 110 o C (hold 5 min) at a 10 o C /min heating rate to 270 o C (hold 2 min) at a 20 o C /min heating rate. Nitrogen was used as the carrier gas with the rate of 1.5 mL/min. A flame ionization detector was employed with hydrogen and air flow rates of 27 mL/min and 250 mL/min, respectively. The injected volume was 0.2 μL and the split ratio was set to 100:1. Qualitative analysis of acrylic monomers ranged from 2 min to 18 min by comparing chromatograms peak position for sample extracts with those of standards in the same concentration range.
To explore drug release behavior of the polymer, a patch (5 cm 2 ) contained oxybutynin was cut from the coated tape and fastened on a steel plate using doublesided adhesive tape (Nanjing A&D Art Decoration Supplies Co., Ltd) and the adhesive layer was exposed to the release medium. The aqueous solution of dihydric phosphate (PH=5.0) was used as the release medium. The steel plate was immersed in the release medium (900 mL). The medium was maintained at 25 o C and stirred at moderate speed (60 rpm) throughout the experiment. At specified time the medium was removed and immediately replaced with 2 ml of fresh medium. The withdrawn medium was filtered through a 0.25 μm filter to remove any particulate matter, and then was assayed to determine drug content in the medium using high-performance liquid chromatography (HPLC) ( Alliance 2690, Waters, USA). The lamda(max) used in the HPLC assay was 220 nm.
Estimation of adhesive characters
Solution was coated in a dry film of 30 μm thickness and dried at room temperature. The films were conditioned 24 h prior to testing at 23±2 o C and 50±2% relative humidity. Stainless steel panels were used as substrates in all tests.
The testing process of peel adhesion was as follows: A 25.4 mm×300 mm specimen was cut and laminated against a stainless steel substrate using a 2040 g rubber coated roller. Dwelling time was 1 min. The testing speed of a tensile tester (Instron Inc.) was 300 mm/min. The average force per 10 mm to peel the specimen from the substrate was reported. Three specimens were tested per sample.
The testing process of tack was as follows: A specimen of 25.4 mm×300 mm was cut. The rolling ball test apparatus was placed at the beginning of the specimen. The different stainless balls were released from the top of the apparatus. The maximum number of the ball could be stopped and was recorded. Three specimens were tested per sample.
The viscosity of a polymer solution is a basilic parameter of the capacity of PSAs polymer, which influences mechanical property of PSAS. The viscosity of PSAs was measured using rotary viscometer (Shanghai Qunchang Scientific Instrument Co., Ltd). Measurements were performed at 25 o C with a polymer solution concentration of 30% in ethyl acetate according to China Pharmacopoeia [15] .
